The Art of Drug Choice: International Panel in Wet AMD: Safety Data

New Retina Radio by Eyetube
10/09/2021 25 min
The Art of Drug Choice: International Panel in Wet AMD: Safety Data

Listen "The Art of Drug Choice: International Panel in Wet AMD: Safety Data"

Descargar episodio

Episode Synopsis

Safety will ultimately drive decision-making for patients with wet AMD. What are the latest safety data in the MERLIN, ARCHWAY, OPTIC, RGX-314, and TENAYA/LUCERNE trials? Moderator Arshad M. Khanani, MD, MA (United States), and panelists Justus G. Garweg, MD (Switzerland), Seenu M. Hariprasad, MD (United States), and Peter Kertes, MD, FRCSC (Canada), sift through the latest safety data to determine how concerns about safety could shape the future of wet AMD therapy. 
This editorially independent podcast is supported with advertising.

More episodes of the podcast New Retina Radio by Eyetube

New Retina Radio Journal Club w/ VBS: Time-Driven Cost Analysis of PRP: Dollars, Minutes, and Patient Care 10/10/2025
The Nuts and Bolts of GA Therapy: The Opening Sessions 09/10/2025
Keeping Patients at the Center of GA Therapy: Preserving Vision vs Restoring Vision 02/10/2025
Keeping Patients at the Center of GA Therapy: Dosing Schedules, AREDS Vitamins, and Photobiomodulation 02/10/2025
Keeping Patients at the Center of GA Therapy: Patient Education and Setting Expectations 02/10/2025
Keeping Patients at the Center of GA Therapy: Social Impact and Early Intervention 02/10/2025
New Retina Radio Journal Club w/ VBS: Aflibercept 8 mg in nAMD: Outcomes After Switching From Faricimab 26/09/2025
ASRS '25: ReCLAIM-2 and Continuous Glucose Monitoring in NPDR 04/09/2025
ASRS '25: PORTAL 5-year Data in Wet AMD, and Home OCT vs Human Graders 21/08/2025
New Retina Radio Journal Club w/ VBS: Obstructive Sleep Apnea and Diabetic Retinopathy 13/08/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA